Dr. Brendan Michael Prendergast, MD

Dr. Prendergast practices at Viera Hospital in Melbourne, Florida, part of Health First.

Dr. Prendergast's NPI, 1497928394, was assigned on April 11, 2008. Dr. Prendergast graduated from University Of Florida College Of Medicine in 2008. Dr. Prendergast holds Florida license ME115355.

Dr. Prendergast's primary practice is Viera Hospital, at 8745 N Wickham Rd, Melbourne, FL 32940 in Brevard County. The practice phone is (321) 434-9000.

Dr. Prendergast's primary practice is Viera Hospital in Melbourne, Florida, part of Health First. Dr. Prendergast is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Prendergast to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prendergast practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Prendergast's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Prendergast is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Prendergast's licenses on file in 3 states: Florida, Alabama and Colorado.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI and colorectal cancer radiation among the conditions Dr. Prendergast treats.

CMS data shows 7,512 Medicare services from Dr. Prendergast across 26 procedure codes in 2024, for 417 Medicare patients. Medicare paid $1,317,784 for them.

CMS counts 417 Medicare patients who saw Dr. Prendergast in 2024. The largest group is 65 to 74, with 177 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prendergast's median patient age at 74, with 37% women.

In 2024, Dr. Prendergast wrote 270 Medicare Part D claims for 112 patients. 81% of them were for generic drugs. CMS names the drug for 171 of them, across 5 drugs with 11 or more claims each, at $2,720 in total drug cost. In 2023, CMS named 189 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Prendergast for performance year 2024, reported through an alternative payment model (APM). Dr. Prendergast accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Prendergast, published from 2009 to 2013. 2012 was the busiest year, with 3. The most frequent topics are Breast Neoplasms and Radiation Injuries. Dr. Prendergast's most frequent co-authors are John B. Fiveash, Sharon Ann Spencer and Grant Michael Clark, MD.

CMS Open Payments shows 101 general payments to Dr. Prendergast from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Novocure Inc. paid the most, $2,256.

Dmand AI lists 1 award for Dr. Prendergast, most recently CMS Stage 1 EHR in 2013.

Dr. Prendergast graduated from University Of Florida College Of Medicine in 2008.

Dr. Prendergast is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.